Journals / Journal of Clinical Research in Pediatric Endocrinology / 2015 / Cilt: 7 - Sayı: 1

Rhizomelic Chondrodysplasia Punctata Type 1 Caused by a Novel Mutation in the PEX7 Gene

Pages
69–72
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, the clinical presentation and peroxisome profile of the patient suggest that this novel mutation leads to RCDP type 1

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Peroxisomes are involved in various metabolic reactions.
📊
Key Findings & Data:Rhizomelic chondrodysplasia punctata (RCDP) type 1 is one of the peroxisomal biogenesis disorders caused by mutations in the PEX7 gene and is inherited in an autosomal recessive manner.
💡
Conclusion & Impact:In conclusion, the clinical presentation and peroxisome profile of the patient suggest that this novel mutation leads to RCDP type 1
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Peroxisomes are involved in various metabolic reactions. Rhizomelic chondrodysplasia punctata (RCDP) type 1 is one of the peroxisomal biogenesis disorders caused by mutations in the PEX7 gene and is inherited in an autosomal recessive manner. We present a nine-year-old boy with skeletal abnormalities and dysmorphic facial appearance. The patient was born to parents who were first cousins. Very-long-chain fatty acids and pristanic acid levels were in the normal range, but an elevated phytanic acid level was detected by gas chromatography/mass spectrometry. The PEX7 gene was sequenced in the patient and his parents. A novel homozygous mutation, c.192delT (p.F64Lfs*10), was identified in the patient and was present in heterozygosity in both parents. In conclusion, the clinical presentation and peroxisome profile of the patient suggest that this novel mutation leads to RCDP type 1

🔖

Cite This Article

ÇİM, A., COŞKUN, S., GÖRÜKMEZ, O., YÜKSEL, H. G., ULUCA, Ü., PİETRO, E. D., PLOURDE, F., BRAVERMAN, N. E. (2015). Rhizomelic Chondrodysplasia Punctata Type 1 Caused by a Novel Mutation in the PEX7 Gene. Journal of Clinical Research in Pediatric Endocrinology, Cilt: 7 - Sayı: 1, 69–72. https://ajindex.com/articles/219772

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (5)

  1. White AL, Modaff P, Holland-Morris F, Pauli RM. Natural history of rhizomelic chondrodysplasia punctata. Am J Med Genet A 2003;118A:332-342.
  2. Wanders RJ, Waterham HR.Peroxisomal disorders I: biochemistry and genetics of peroxisome biogenesis disorders. Clin Genet 2005;67:107-133.
  3. Waterham HR, Ebberink MS. Genetics and molecular basis of human peroxisome biogenesis disorders. Biochim Biophys Acta 2012;1822:1430-1441. Epub 2012 Apr 25 Hettema EH, Erdmann R, van der Klei I, Veenhuis M. Evolving models for peroxisome biogenesis. Curr Opin Cell Biol 2014;29:25-30. Epub 2014 Mar 28 Braverman N, Chen L, Lin P, Obie C, Steel G, Douglas P, Chakraborty PK, Clarke JT, Boneh A, Moser A, Moser H, Valle D. Mutation analysis of PEX7 in 60 probands with rhizomelic chondrodysplasia punctata and functional correlations of genotype with phenotype. Hum Mutat 2002;20:284-297.
  4. Braverman N, Steel G, Lin P, Moser A, Moser H, Valle D. PEX7 gene structure, alternative transcripts, and evidence for a founder haplotype for the frequent RCDP allele, L292ter. Genomics 2000;63:181-192. Braverman N. Longitudinal Natural History Study of Patients With Peroxisome Biogenesis Disorders (PBD). In: ClinicalTrialsgov [Internet] Bethesda (MD): National Library of Medicine (US) 2000. [cited 2014 Nov 17];Available from: http://clinicaltrials.gov/ct2/show/study/NCT01668186 NLM Identifier: NCT01668186. Braverman N, Argyriou C, Moser A. Human Disorders of Peroxisome Biogenesis: Zellweger Spectrum and Rhizomelic Chondrodysplasia Punctata. Molecular Machines Involved in Peroxisome Biogenesis and Maintenance: Springer; 2014:63- 90. Wardinsky TD, Pagon RA, Powell BR, McGillivray B, Stephan M, Zonana J, Moser A. Rhizomelic chondrodysplasia punctata and survival beyond one year: a review of the literature and five case reports. Clin Genet 1990;38:84-93.
  5. Buchert R, Tawamie H, Smith C, Uebe S, Innes AM, Al Hallak B, Ekici AB, Sticht H, Schwarze B, Lamont RE,Parboosingh JS, Bernier FP, Abou Jamra R. A peroxisomal disorder of severe intellectual disability, epilepsy, and cataracts due to fatty acyl-CoA reductase 1 deficiency. Am J Hum Genet 2014;95:602-610. Epub 2014 Oct 30 Brites P, Waterham HR, Wanders RJ.Functions and biosynthesis of plasmalogens in health and disease. Biochim Biophys Acta 2004;1636:219-231.